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ABSTRACT: We investigate the properties of an antimicro-
bial surfactant-like peptide (Ala)6(Arg), A6R, containing a
cationic headgroup. The interaction of this peptide with
zwitterionic (DPPC) lipid vesicles is investigated using a range
of microscopic, X-ray scattering, spectroscopic, and calori-
metric methods. The β-sheet structure adopted by A6R is
disrupted in the presence of DPPC. A strong eﬀect on the
small-angle X-ray scattering proﬁle is observed: the Bragg
peaks from the DPPC bilayers in the vesicle walls are
eliminated in the presence of A6R and only bilayer form factor
peaks are observed. All of these observations point to the interaction of A6R with DPPC bilayers. These studies provide insight
into interactions between a model cationic peptide and vesicles, relevant to understanding the action of antimicrobial peptides on
lipid membranes. Notably, peptide A6R exhibits antimicrobial activity without membrane lysis.
■ INTRODUCTION
Surfactant-like peptides (SLPs) have a remarkable ability to
self-assemble into diﬀerent nanostructures, primarily due to
their amphiphilic nature. For example, they can aggregate into
high aspect ratio structures while displaying bioactive peptides.
SLPs are a class of amphiphilic peptide comprising a headgroup
which is a short sequence of charged residues attached to a
tailgroup of neutral residues.1,2 Pioneering work on SLPs has
been conducted by the Zhang group including A6D, V6D, V6D2
and L6D2.
3,4 We have recently investigated the self-assembly of
a cationic peptide which consists of six consecutive hydro-
phobic alanine residues as a tailgroup with a cationic arginine
headgroup.5 We reported that this SLP can self-assemble into
ultrathin sheets at low concentrations and at higher
concentrations the sheets wrap around to form nanotubes
and helical ribbons.
Peptides rich in arginine are known to have antimicrobial
activities.6−9 An example includes the transcription activating
peptide, TAT [transactivator of transcription] from HIV-1,
which has been reported to have antimicrobial properties.10,11
The TAT peptide is 11 amino acids long, and it is highly basic
as it contains six arginine and two lysine residues. It was found
that substitution of any of the basic residues with a neutral
amino acid causes a reduction of antimicrobial activity, which
arises from its ability to bind to cell membranes.9 Arginine
contains a guanidinium group which adopts a planar Y-shape,
which can delocalize the cationic charge. As a result arginine
can form bidentate hydrogen bonds with phosphates in lipid
headgroups as well as electrostatic interactions. As arginine
interacts with cell membranes, this can lead to negative
curvature and subsequently to cell leakage giving rise to
antimicrobial properties.9,10,12
Our group previously investigated the self-assembly of a
peptide amphiphile (PA) hexadecyl-β-alanine-histidine (C16-
βAH) along with mixtures of multilamellar DPPC vesicles.13
We observed that the PA self-assembles into nanotapes based
on lamellae, that is, stacked bilayers. Mixing the PA with DPPC
caused a transition from multilamellar to unilamellar vesicles.
Moshe et al. have studied the interactions of a designer cell-
penetrating peptide (CPP) with phospholipids including
DOPC and DOPE.14 The peptide consisted of an arginine
residue with two short hydrophobic moieties either side to
create hydrophobic and electrostatic interactions. At low
concentrations, below the critical aggregation concentration,
the peptide was reported to insert in the lipid bilayers and cause
a reduction in the membrane thickness. The CPP was found to
change the charge of the DOPC membrane and even cause a
phase transition in DOPE from an inverted hexagonal to a
multilamellar phase. These observations were ascribed to a
change in the delicate balance of the hydrophobic, electrostatic
interactions and steric eﬀects.
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Yaghmur et al. examined the eﬀect of both anionic (A6D)
and cationic (A6K) SLP’s on the bicontinuous cubic phase
(Pn3 ̅m) of mono-olein.15 At low concentrations of A6D, a
bicontinuous cubic structure is retained, and only at high
concentrations of the peptide a phase transition to an inverted
hexagonal phase occurs. The addition of A6K to mono-olein
had no eﬀect on the phase transition. These observations were
attributed to the ability of A6D to fully penetrate the membrane
interface in contrast to A6K which essentially does not
penetrate the membrane due to electrostatic repulsion. As
A6D is inserted, destabilization of the lipid bilayer occurs,
leading to negative curvature in the membrane interface.
Previously, our group studied the inﬂuence of anionic and
nonionic surfactants (sodium dodecyl sulfate16 and Pluronic
P123,17 respectively) on the self-assembly of a collagen
stimulating PA, C16-KTTKS. The PA is known to self-assemble
into extended nanotapes in solution.18 Both surfactants
inﬂuenced the self-assembly of C16-KTTKS since morpho-
logical transitions from nanotapes to ﬁbrils were observed.
Here we report on the antimicrobial properties of A6R. Then
we attempt to understand by investigating the eﬀect of the
cationic peptide A6R on the structure of model zwitterionic
lipid (DPPC) vesicles using a combination of microscopic,
spectroscopic, and scattering techniques. DPPC vesicles were
selected as a model system, building on previous work in our
group on lipopeptide/vesicle interactions.19 Actually, DPPC is a
suitable model for mammalian cell membranes, but not
bacterial membranes.20 Other mixtures containing zwitterionic
lipids have been used to model eukaryotic membranes.14,21
Bacterial membranes are typically rich in anionic lipids such as
POPG (oleoyl-1-palmitoyl-sn-glycero-3-phosphoglycerol) or
DPPG (1,2-dipalmitoyl-sn-glycero-3-phosphoglycerol).20,22,23
The self-assembly of A6R has been thoroughly characterized
by us previously.5 It is therefore of practical as well as
fundamental interest to characterize the peptide−lipid inter-
actions to further enhance our understanding of the mechanism
of binding and to improve the development of antimicrobial
applications for the future.
■ EXPERIMENTAL SECTION
Materials. Peptide NH2-AAAAAAR-COOH, referred to as A6R,
was custom synthesized by CS Bio Company (Menlo Park, CA) and
was received as the TFA salt variant. The purity was 97.01% by HPLC
in water/acetonitrile (0.1% TFA). Electrospray-ionization mass
spectroscopy (ESI-MS) indicated a molar mass 600.87 g mol−1
(600.69 g mol−1, expected).
Control peptide A6D was purchased from CS Bio. Purity was
99.87% by HPLC in water/acetonitrile (0.1% TFA). ESI-MS indicated
a molar mass 559.33 g mol−1 (559.59 g mol−1, expected).
The phospholipid, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine,
DPPC, was purchased from Sigma Aldrich, and has a molecular
weight of 734.05 g mol−1.
Bacterial Strains and Growth Media. Escherichia coli O157
strain BW25113, the parent strain of the Keio collection, was kindly
provided by Professor H. Mori, Keio University, Japan. Staphylococcus
aureus NCDO 949 was originally from the collection of the National
Institute for Research in Dairying, now listed as NCIMB 13062.
Strains were maintained as frozen stocks at −70 °C on Cryobeads
(Prolab Diagnostics, Neston, U.K.), which were plated onto nutrient
agar (NA, Oxoid) and incubated at 37 °C overnight (16−18 h) to
obtain single colonies before storage at 4 °C. Experimental cultures
were prepared by inoculating a single colony into 10 mL of tryptone
soy broth (TSB) supplemented with 0.3% (w/v) yeast extract (TSBY),
and incubating statically for 6 h at 37 °C. This culture was then
subcultured into a fresh broth of TSB and incubated with shaking at
180 rev min−1 overnight at 37 °C before use. Viability was assessed by
diluting samples in Maximum Recovery Diluent (MRD, Oxoid), and
plating 0.02 mL volumes onto nutrient agar. Plates were incubated at
37 °C, and colonies were counted after 48 h. Colony counts were
calculated by colony forming units (CFU) equal to number of colonies
times dilution factor times volume (CFU = N × dilution factor × V).
Preparation of Cell Suspensions. Cells were harvested by
centrifugation at 1300 rpm, 5 °C, for 5 min. The pellet was
resuspended in 1.5 mL of ice-cold phosphate-buﬀered saline (PBS, pH
7.0, Sigma-Aldrich), and 20 μL of this solution was diluted into 200 μL
of peptide solution (5, 2.5, 1, 0.5 mg/mL) to give approximately 107
cells mL−1. Control solutions were achieved by adding no peptide
solution but MRD instead. These solutions were vortexed for 3 s and
left for set time intervals (10, 20, 30, 40, 50, 60 min) before diluting
with MRD and plating. Plates were then incubated at 37 °C overnight
for 18−24 h, followed by a cell count (CFU calculation).
Sample Preparation. Vesicle Preparation. DPPC vesicles were
prepared by the thin layer hydration method to ensure the formation
of multilayered vesicles.24 A measured quantity of DPPC was dissolved
in ethanol and placed into a 100 mL round-bottom ﬂask. The solvent
was evaporated by using a rotary evaporator, which formed a thin
DPPC ﬁlm at the bottom of the ﬂask. A measured quantity of water
was added to the ﬂask to make up the deﬁned concentration. The ﬂask
was returned to the rotary evaporator, which was rotated while at 50
°C by submerging it under a water bath. The solution was then
vortexed at 50 °C for approximately 5 min.
Solution Mixture Preparation. Solutions of 0.5, 1, and 2 wt %
DPPC vesicles were ﬁrst prepared followed by the addition of 1 wt %
A6R. A measured quantity of A6R powder was added to a solution of
DPPC vesicles to make up the three diﬀerent solutions with diﬀerent
proportions of DPPC. The mixture was left to sonicate for 30 min at
50 °C to dissolve A6R. Then the solution was left to equilibrate at
room temperature for a few days before any measurements.
Cryogenic-Transmission Electron Microscopy (Cryo-TEM).
Imaging was carried out using a ﬁeld emission cryo-electron
microscope (JEOL JEM-3200FSC), operating at 200 kV. Images
were taken in bright ﬁeld mode and using zero loss energy ﬁltering
(omega type) with a slit width of 20 eV. Micrographs were recorded
using a Gatan Ultrascan 4000 CCD camera. The specimen
temperature was maintained at −187 °C during the imaging. Vitriﬁed
specimens were prepared using an automated FEI Vitrobot device
using Quantifoil 3.5/1 holey carbon copper grids with a hole size of
3.5 μm. Just prior to use, grids were plasma cleaned using a Gatan
Solarus 9500 plasma cleaner and then transferred into an environ-
mental chamber of a FEI Vitrobot at room temperature and 100%
humidity. Thereafter, 3 mL of sample solution was applied on the grid
and it was blotted twice for 5 s and then vitriﬁed in a 1/1 mixture of
liquid ethane and propane at temperature of −180 °C. The grids with
vitriﬁed sample solution were maintained at liquid nitrogen temper-
ature and then cryo-transferred to the microscope.
X-ray Diﬀraction (XRD). Measurements were performed on stalks
prepared by drying ﬁlaments of solutions containing 1 wt % A6R mixed
with 0.5, 1, and 2 wt % DPPC. Solutions of the mixtures were
suspended between the ends of wax-coated capillaries and dried. The
stalks were mounted (vertically) onto the four axis goniometer of a
RAXIS IV++ X-ray diﬀractometer (Rigaku) equipped with a rotating
anode generator. The sample−detector distance varied between 90
and 100 mm depending on the sample. The X-ray wavelength was λ =
1.54 Å. The wavenumber scale (q = 4π sin θ/λ, where 2θ is the
scattering angle) was geometrically calculated using the size of each
pixel in the detector screen (0.0898 mm) and the sample−detector
distance. The XRD data was collected using a Saturn 992 CCD
camera.
Small-Angle and X-ray Scattering (SAXS). Solution SAXS data
was performed on the bioSAXS beamline BM29 at the ESRF,
Grenoble, France. Solutions containing 1 wt % A6R and 1 wt % A6R
mixed with 0.5, 1, and 2 wt % DPPC were loaded in PCR tubes in an
automated sample changer. SAXS data was collected using a Pilatus 1
M detector. The sample−detector distance was 2.84 m. The X-ray
wavelength was 0.99 Å.
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Circular Dichroism (CD). Spectra were obtained using a Chirascan
spectropolarimeter (Applied Photophysics, UK). CD was performed
on solution mixtures containing DPPC vesicles with A6R added later,
with a 0.5 nm step, 1 nm bandwidth and 1 s collection time per step at
20 °C. Data with absorbance A < 2 only are presented. Measurements
were repeated four times. Smoothing of the data was carried out using
the supplied Chirascan software.
Isothermal Titration Calorimetry (ITC). ITC experiments were
carried out using an iTC200 microcalorimeter from MicroCal Inc. The
working cell was ﬁlled with 200 μL of 0.1 wt % DPPC solution
(dissolved in water) and the reference cell was ﬁlled with deionized
water. The titrant syringe was ﬁlled with a solution of 1 wt % A6R. The
ITC experiment was programmed to run 20 injections of 2 μL volume
of the titrant solution (1 wt % A6R) into the working cell (0.1 wt %
DPPC) with 300 s lag between each injection to ensure return to the
baseline. The syringe was stirred throughout the experiment at 500
rpm and the working cell was set at 25 °C. The data was analyzed
using Origin 7 (MicroCal) by ﬁtting the curve using the one set of
sites model.
■ RESULTS
Since many antimicrobial peptides contain arginine resi-
dues,8,9,25,26 it is of interest to investigate the antimicrobial
activity of model arginine-containing peptides such as A6R. The
antibacterial activity of this peptide was assayed against Gram
positive S. aureus and Gram negative E. coli. Against S. aureus in
particular, peptide A6R shows a signiﬁcant time-dependent
reduction in the number of colony-forming units as shown in
Figure 1, in contrast to the control (culture medium only). At
the highest peptide concentration used (5 mg/mL), a reduction
in the number of colony-forming bacteria to approximately 15−
25% of their initial number was observed after 1 h, with the
reduction being larger the higher the peptide concentration. At
the higher peptide concentration, the reduction is also greater
for S. aureus than for E. coli (data shown in Supporting
Information (SI) Figure 1a). As an additional control, the same
protocol was followed but using peptide A6D. Despite having
an anionic (aspartic acid) headgroup rather than a cationic one,
this peptide does exhibit some antibacterial activity (SI Figure
1b,c), although greatly reduced compared to A6R. Peptide A6D
also showed greater activity against S. aureus than E. coli. The
antibacterial activity of A6R is larger than the reported 35- 45%
reduction in number of bacteria (E. coli or S. aureus) for A6K to
55−65% surviving bacteria, although this peptide was studied
only at lower concentration (up to 0.2 mg/mL).27 Peptide A9K
showed better activity, in particular a reduction by 80% in
numbers of E. coli and 70% of S. aureus after 1 h for an 0.1 mg/
mL sample.27
Having established the antimicrobial properties of A6R, we
set out to examine the origin of this eﬀect in terms of
interactions between the peptide and model lipid membranes,
using DPPC vesicles. To investigate the binding interactions of
A6R with DPPC, CD spectroscopy was employed, along with
other methods to be described shortly. Figure 2 presents CD
spectra for 1 wt % A6R on its own and with mixtures of 0.5, 1,
and 2 wt % DPPC. The spectra show that A6R adopts a β-sheet
structure as a minimum at approximately 220 nm is observed.28
This is consistent with our previous ﬁber XRD data, which
revealed a β-sheet spacing.5 Mixing of DPPC vesicles with A6R
leads to a spectrum indicative of a polyproline II (PPII) helix.
The presence of a broad maximum band at ∼220 nm due to π0
→ π* (parallel electronic transition) and a minimum between
190 and 200 nm arising from the π0 → π* (perpendicular
electronic transition) is characteristic of a PPII helix.29 Detailed
modeling of the change in peptide conformation on binding to
the DPPC bilayer is beyond the scope of the present Article;
however, it may be mentioned that many surface-active
peptides undergo conformational changes upon binding to
lipid membranes, for example, as well as antimicrobial
peptides,7 this has been very well studied for the amyloid β
peptide.30 It is clear that the CD spectrum from the mixture is
completely diﬀerent from that of A6R on its own and cannot be
expressed as a superposition of the spectra from the species in
the mixture, which indicates interactions between the peptide
and lipid vesicles.
Cryo-TEM images from solutions of 0.5, 1, and 2 wt %
DPPC vesicles are shown in Figure 3a−c, respectively. The
images reveal a variation in the size of the vesicles. The size of
the vesicles varies greatly from approximately 150 nm to 2 μm
or more. It was observed that smaller vesicles were often found
inside larger vesicles. Sheets of DPPC not forming vesicles were
also observed in the 0.5 wt % DPPC sample. As the
concentration of DPPC increases from 0.5 to 1 wt %, a
reduction in the number of sheets not forming vesicles was
noted as well as a decrease in the fraction of larger vesicles.
Upon addition of A6R to a solution of DPPC, the multiwall
vesicle structure is retained as shown in Figure 3d−f. For low
DPPC concentration, the overall size of the vesicles largely
remains the same as those of DPPC vesicles in the absence of
A6R; however, the size distribution of vesicles shifted toward
smaller particles for 1 wt % A6R + 2 wt % DPPC. Notably, the
Figure 1. Antimicrobial testing results for A6R with S. aureus. Dose and
time dependence of colony forming units.
Figure 2. CD spectra of solutions of 1 wt % A6R mixed with varying
concentrations of DPPC compared with 1 wt % A6R on its own.
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addition of A6R does not cause membrane disruption and break
up of vesicles.
Microscopy can provide valuable information; however, to
provide nonlocal information on the average nanostructure,
SAXS was employed to compliment the cryo-TEM images and
to further elucidate the inﬂuence of A6R on the structure of the
DPPC walls. SAXS intensity proﬁles for A6R/DPPC mixtures
are plotted along with their individual components for
comparison as shown in Figure 4. The data for 1 wt% A6R
has been presented before and reveals the self-assembly of the
peptide into ﬂat sheet-like nanostructures.5 The DPPC
phospholipid vesicles were prepared by using the rehydration
method to ensure the development of multilamellar vesicles.24
The SAXS curves for 0.5 wt %, 1 wt % and 2 wt % DPPC
contain of structure factor peaks, which are due to a stacking
arrangement within the multilamellar walls. A periodicity of
64.8 Å was obtained from the highest order of diﬀraction for
both 0.5 wt % and 1 wt % DPPC, which is in good agreement
with previous literature.31−36 A contribution of a bilayer form
factor as well as structure factor due to the stacking
arrangement of the DPPC walls is present and therefore was
taken into consideration when ﬁtting the SAXS intensity proﬁle
for DPPC using the modeling software, SASﬁt.37 A ﬁt to a
model comprising a Gaussian bilayer form factor along with a
modiﬁed Caille ́ structure factor (described in our previous
work13) for 1 wt % DPPC is presented in Figure 5a, and the
ﬁtting parameters are listed in Table 1. A ﬁt to the SAXS proﬁle
for 0.5 wt % DPPC is shown in SI Figure 2. The SAXS curves
for the mixtures are well ﬁtted to a Gaussian bilayer form factor
excluding the modiﬁed Caille ́ structure factor since the
structure factor peaks are no longer present.
SAXS conﬁrms a multilamellar architecture for DPPC in the
vesicle walls with a period of 64.8 Å. This value is too small to
Figure 3. Cryo-TEM images of DPPC vesicles of varying concentrations containing (a) 0.5 wt %, (b) 1 wt %, and (c) 2 wt %. Images of 1 wt % A6R
solution mixed with (d) 0.5 wt % DPPC, (e) 1 wt % DPPC, and (f) 2 wt % DPPC.
Figure 4. SAXS one-dimensional proﬁles comparing the diﬀerent ratio
mixtures of 1 wt % A6R with DPPC vesicles and its individual
components. The SAXS curves have been shifted to enable
visualization of the data.
Figure 5. SAXS proﬁles for (a) 1 wt % DPPC ﬁtted to a Gaussian
bilayer form factor along with a modiﬁed Caille ́ structure factor and
(b) 1 wt % A6R + 1 wt % DPPC ﬁtted to a Gaussian bilayer form
factor.
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observe the stacking arrangement within the vesicle walls using
cryo-TEM. As A6R is inserted in the bilayers, cryo-TEM
suggests the retention of multilamellar vesicles, which are
noticeable in Figure 3. However, the SAXS structure factor
peaks are lost (Figure 5b and SI Figure 2b). This indicates that
the local multilamellar order is disrupted, possibly due to
swelling eﬀects (cryo-TEM shows multilayer vesicles with a
vesicle wall spacing much larger than 6.5 nm). The profound
change in SAXS intensity proﬁles, suggests that A6R has
inserted in the lipid bilayers. Since DPPC is zwitterionic it is
likely that A6R interacts with the negative charge on the
phosphate group favoring insertion into the bilayer.
Fiber XRD stalks dried from solution were employed to
obtain further structural detail in the wider angle regions.
Representative XRD patterns are shown in SI Figure 3.
Equatorial and meridional XRD intensity proﬁles for 1 wt %
DPPC and 1 wt % A6R mixed with 1 wt % DPPC are shown in
Figure 6. The one-dimensional intensity proﬁle for 1 wt %
DPPC exhibits several peaks corresponding to second, third
and fourth order reﬂections associated with the multilayer
structure of DPPC, which can be observed especially for a 2 wt
% sample as shown in SI Figure 4c. In addition, a peak with a d-
spacing of 4.2 Å can also be observed. This peak has been
previously reported for DPPC, and was ascribed to the
hexagonal packing of the fatty acid side chains of
phospholipid.38,39 The 4.2 Å lipid chain spacing is still present
upon the addition of A6R to DPPC in 1:1 (Figure 6), 1:0.5 and
1:2 (SI Figure 4) mixtures. An additional 5.42 Å reﬂection was
also observed for the mixtures. Recently we reported a 5.5 Å
spacing for dilute concentrations (0.5% - 4%) of A6R, which
was assigned to the polyalanine β-sheet spacing.5 This suggests
that some β-sheet like ordering is retained, possibly due to the
presence of a population of DPPC-free A6R sheets or due to
the presence of “rafts” of ordered A6R within the DPPC vesicle
walls. However, circular dichroism spectroscopy (Figure 1)
indicates the absence of a signiﬁcant β-sheet content globally in
the system under the same conditions.
To further probe the possible interactions between A6R and
DPPC we employed isothermal titration calorimetry. ITC is a
well-known technique to enable investigation of the molecular
interactions of biological samples, in this case a peptide-lipid
interaction. A solution of 1 wt % A6R was injected into 0.1 wt %
DPPC since A6R is the ligand and DPPC acts as the receptor. A
low concentration of DPPC was selected for ITC to reduce the
total number of binding sites to ensure saturation of A6R
binding to DPPC was reached. The ITC proﬁle for the titration
of A6R into DPPC is presented in Figure 7, which exhibits a
series of negative peaks, indicating an exothermic reaction. The
integration and normalization of the exothermic peaks
produced a sigmoidal curve relative to the moles of ligand
added, which was then appropriately ﬁtted to a one set of sites
model. The one set of sites model was used for the peptide/
lipid system as it is assumed that each binding site has the same
binding aﬃnity. A binding constant K = 1.25 × 105 M−1 was
determined from the ﬁtting parameters. Other parameters
including the number of binding sites N = 0.3, enthalpy ΔH =
−3817 J mol−1 and entropy ΔS = 4.84 J mol−1 K−1 were also
obtained from the ﬁt.
Previous studies have examined binding in peptide/lipid
mixtures. Domingues et al. investigated the binding of an 18
amino acid long antimicrobial peptide interacting with charged
large unilamellar vesicles (LUVs).40 They reported that the
binding of the peptide to LUVs is mainly an exothermic
Table 1. Parameters for Fits to SAXS Data Shown in Figure 5
and SI Figure 2 Determined from SASﬁt
sample σout bout σcore bcore N d [Å] η
0.5 wt % DPPC 0.09 0.01 0.59 −0.002 4 63.6 0.15
1 wt % DPPC 0.09 0.01 0.54 −0.002 3 63.6 0.25
1 wt % A6R +
0.5% DPPC
0.10 0.02 1.04 −0.002
1 wt % A6R + 1%
DPPC
0.57 0.01 1.80 −0.005
Figure 6. XRD one-dimensional radial proﬁles (equatorial and
meridional radial averages) for 1 wt % DPPC and 1 wt % A6R + 1
wt % DPPC with indicated d-spacings. The XRD curves have been
shifted to enable visualization of the data. Line colors: 1% DPPC, black
= equatorial and red = meridional; 1% A6R + 1% DPPC, green =
equatorial and blue = meridional.
Figure 7. ITC proﬁle for 1 wt % A6R solution injected into a solution
of 0.1 wt % DPPC.
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process. The binding of a cationic pentapeptide composed of
analogs of lysine resides to negatively charged phospholipid,
DPPG was investigated.41 It was reported that an exothermic
reaction occurs upon binding. A binding constant, K = 5.4 ×
105 M−1, was determined, which is a similar value to the one we
obtained. The Vogel group also investigated the binding of an
antimicrobial peptide, Ac-FRWWHR-NH2 to POPG vesicles,
which reveal an exothermic reaction and a binding constant, K
= 3.13 × 105 M−1.42 The mentioned examples are in good
agreement with our observations that an exothermic process
occurs during binding and the binding constant values are
similar to those we obtained.
■ SUMMARY AND DISCUSSION
In summary, A6R interacts with DPPC vesicles leading to
changes in the vesicle wall layer spacing such that the SAXS
structure factor peaks present for DPPC vesicles are eliminated
and only the form factor of isolated bilayers is observed. This is
similar to what is observed for the interaction of the peptide
amphiphile C16-βAH (βAH: β-alanine-histidine dipeptide,
known as L-carnosine) with DPPC.13 X-ray diﬀraction indicates
the presence of a fraction of tightly packed alanine-rich β-sheet
structures in the A6R/DPPC mixtures, although circular
dichroism spectroscopy shows the suppression of global β-
sheet ordering of A6R in the presence of DPPC. Some A6R may
form separate β-sheet assemblies or “rafts” of ordered A6R may
be present in the vesicle walls. Discriminating between these
possibilies is a challenge for future work.
Interestingly, A6R does not seem to permeabilize DPPC
vesicles despite its insertion into the vesicle walls (as inferred
from dramatic changes in the SAXS intensity proﬁles). Addition
of the peptide leads to the loss of structure factor peaks. This is
the opposite of the behavior observed by Moshe et al. for their
GFfWG (f: D-phenylalanine) peptide interacting with model
cell membranes (DOPS, DOPC, DOPE mixture) since a series
of Bragg reﬂections were observed in the presence of the
peptide, but only form factor (similar to that shown in our
Figure 4b) features were observed for the membrane/lipid
mixture.14
Hoernke et al. reported that short basic pentapeptides such
as K5 insert into lipid (DPPG) membranes,
41 in contrast to the
ﬁndings of Ben-Tal et al.43 However, in neither of these studies
was imaging of vesicles or permeabilization measurements
performed. The hexapeptide FRWWHR, identiﬁed by
combinatorial screening methods to have strong antimicrobial
activity, does not cause substantial leakage from vesicles, and
Rezansoﬀ et al. suggested that the bactericidal action of the
peptide may involve translocation across the membrane.42
However, Blondelle et al. did observe lysis of model DPPC-
containing membranes in the presence of lysine-rich 18-mer
peptides.44 Natural antimicrobial peptides such as magainin45,46
and gomesin40 permeabilize membranes and lead to lysis. Some
cationic peptides are known to cause fusion of cell membranes
and have been studied in particular in the context of viral
infection where they mediate fusion of the host cell membrane
and the enveloped virus. The fusogenic TAT protein
transduction domain has been used to deliver a wide range of
biologically active cargo (DNA, proteins, liposomes, and
others).47 The initial model for cellular uptake involves direct
penetration across the lipid membrane, however it has been
shown that TAT-fusion proteins are rapidly internalized by
lipid-raft dependent macropinocytosis47 (pinocytosis is non-
speciﬁc endocytosis within vesicles). As mentioned above,
substitution of any of the basic residues in the TAT peptide
with a neutral amino acid causes a reduction of antimicrobial
activity, reﬂecting the inﬂuence of charge and hydrophobicity.9
Thus, prior work indicates that membrane permeabilization
can occur for peptides with more than one cationic residue, but
this alone is not suﬃcient. The sequence and length of the
peptide is also important, as is the nature and composition of
the lipid membrane. This was highlighted by Chen et al. in their
comparison of the antibacterial properties of A3K, A6K, and
A9K.
27 They found that the latter, which has the longest
hydrophobic alanine block and the strongest aggregation
tendency, has the highest antimicrobial activity. This peptide
also did not signiﬁcantly disrupt DPPC vesicles, although
DPPG membranes were broken up. Even relatively short
peptides righ in arginine and/or tryptophan have potent
antimicrobial activity.26 Other factors inﬂuencing the activity of
antimicrobial peptides are discussed elsewhere.48 As discussed
in the Introduction, models for bacterial cell membranes should
consist of anionic lipids although as discussed above many
studies have used DPPC as model membranes.
We have shown that A6R is a model antimicrobial cationic
peptide containing a single arginine residue attached to a
hydrophobic hexa-alanine sequence to drive self-assembly. This
study provides insight into its interaction with model lipid
membranes. It also introduces the concept of addition of SLPs
to modulate the structure of lipid vesicles. Remarkably, A6R
exhibits antimicrobial activity without zwitterionic lipid
membrane lysis.
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